Median and 5th–95th percentile of 300 simulated subjects per dose from a triexponential model with between-subject variability. Every figure on this page is generated in your browser from made-up parameters and contains no study data.
Population PK, exposure–response and dose simulation for a first-in-human LNP therapy
Model-informed drug development for a dose-escalation study: datasets built from SDTM, population PK and PKPD models, exposure–response for efficacy and safety, and virtual-population dosing simulations. The whole pipeline was then audited and rebuilt in free, open-source R.
Walk through the seven steps →